Read-Gene S.A. (WSE:RDG)
6.06
-0.14 (-2.26%)
At close: Sep 8, 2025
Read-Gene Market Cap
Read-Gene has a market cap or net worth of 67.67 million as of September 12, 2025. Its market cap has increased by 6.30% in one year.
Market Cap
67.67M
Enterprise Value
67.09M
Revenue
15.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.06
Market Cap Chart
Since February 12, 2009, Read-Gene's market cap has increased from 31.83M to 67.67M, an increase of 112.59%. That is a compound annual growth rate of 4.65%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 12, 2025 | 67.67M | 15.73% |
Dec 30, 2024 | 58.48M | -14.48% |
Dec 29, 2023 | 68.38M | 124.81% |
Dec 30, 2022 | 30.42M | -8.19% |
Dec 29, 2021 | 33.13M | 8.08% |
Dec 30, 2020 | 30.65M | 293.94% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Diagnostyka | 7.16B |
NEUCA | 3.17B |
Synektik Spólka Akcyjna | 1.99B |
Voxel | 1.79B |
Celon Pharma | 1.18B |
Ryvu Therapeutics | 658.92M |
Selvita | 585.54M |
Centrum Medyczne ENEL-MED | 511.87M |